
Overview
Samir Abraksia is a Hematologist Oncology provider practicing medicine in Warrensville Heights, Ohio. He has been practicing medicine for over 45 years.
Dr. Abraksia is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Hereditary Resistance to Anti-Vitamin K, Protein S Deficiency, and Congenital Antithrombin 3 Deficiency.
Dr. Abraksia is board certified in American Board Of Internal Medicine, 1997. He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 3 clinical trials.
Graduate Institution
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- PPO
- MEDICARE SNP
- MEDICARE MAPD
- OTHER MEDICARE
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- PPO
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE PART D
- MEDICARE SNP
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20050 Harvard Avenue, Warrensville Heights, OH 44122
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Cleveland Clinic Main Campus
Gary Schwartz is a Hematologist Oncology provider practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 47 years. Dr. Schwartz is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Fibrosarcoma, Hepato-Pancreato-Biliary Surgery, and Liver Embolization. Dr. Schwartz is board certified in American Board Of Internal Medicine, 1986.
Cleveland Clinic Main Campus
Brian Hill is a Hematologist Oncology specialist and a Hematologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 30 years. Dr. Hill is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Cleveland Clinic Main Campus
Paolo Caimi is a Hematologist Oncology specialist and a Hematologist practicing medicine in Cleveland, Ohio. Dr. Caimi is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Caimi is board certified in American Board Of Internal Medicine, 2011.
Frequently Asked Questions about Dr. Samir Abraksia
How do I make an appointment with Dr. Samir Abraksia?
You can book an appointment with Dr. Samir Abraksia by calling their office at 216-491-6000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Samir Abraksia a top-rated expert for Myeloproliferative Neoplasms (MPN)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Samir Abraksia is classified as an Distinguished expert for Myeloproliferative Neoplasms (MPN), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Samir Abraksia specialize in?
While Dr. Samir Abraksia is a Hematology Oncology, they have specific expertise in Myeloproliferative Neoplasms (MPN), Hereditary Resistance to Anti-Vitamin K, and Protein S Deficiency. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Samir Abraksia participate in research or clinical trials?
Yes. Dr. Samir Abraksia has published 1 articles and abstracts on conditions like Myeloproliferative Neoplasms (MPN). You can view a list of Dr. Samir Abraksia's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Samir Abraksia accept my insurance?
Dr. Samir Abraksia accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 216-491-6000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Congenital Antithrombin 3 DeficiencyDr. Abraksia isDistinguished. Learn about Congenital Antithrombin 3 Deficiency.
- Hereditary Resistance to Anti-Vitamin KDr. Abraksia isDistinguished. Learn about Hereditary Resistance to Anti-Vitamin K.
- Myeloproliferative Neoplasms (MPN)Dr. Abraksia isDistinguished. Learn about Myeloproliferative Neoplasms (MPN).
- Protein C DeficiencyDr. Abraksia isDistinguished. Learn about Protein C Deficiency.
- Protein S DeficiencyDr. Abraksia isDistinguished. Learn about Protein S Deficiency.
- Advanced
- Acquired AgranulocytosisDr. Abraksia isAdvanced. Learn about Acquired Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Abraksia isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Abraksia isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Abraksia isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Abraksia isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Experienced
- Acute Mountain SicknessDr. Abraksia isExperienced. Learn about Acute Mountain Sickness.
- Adult Soft Tissue SarcomaDr. Abraksia isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Abraksia isExperienced. Learn about Agranulocytosis.
- B-Cell LymphomaDr. Abraksia isExperienced. Learn about B-Cell Lymphoma.
- Bladder CancerDr. Abraksia isExperienced. Learn about Bladder Cancer.
- Blood ClotsDr. Abraksia isExperienced. Learn about Blood Clots.



